|
BioPharma Credit PLC - London-based closed-ended investment company focused on the life sciences industry - Regarding Alphatec Holdings Inc, BioPharma Credit notes the prepayment in full of its $200 million senior secured loan facility, of which it had an investment of $35 million. BioPharma Credit says it earned a 14.91% gross internal rate of return and an 11.93% net internal rate of return on its Alphatec Holdings investment. Alphatec on Tuesday announced it entered into a new credit facility, including a $125 million revolving credit facility and a $175 million term loan A. Current stock price: 69.03 pence each, down 0.7% on Wednesday at around noon in London 12-month change: up 6.9% Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
